CHLORHEXIDINE GLUCONATE | N019822 | KW GRIFFEN CO
| Trial | Phase | Status | Sponsor | Enrollment | Dates |
|---|---|---|---|---|---|
| Phase 2 | Active | Janssen Research & Development, LLC | 305 | 2024-02-16 → 2030-06-30 | |
| N/A | Active | CMH Lahore Medical College and Institute of Dentistry | 174 | 2026-02-14 → 2026-10-28 | |
| Phase 3 | Active | Rush University Medical Center | 200 | 2023-12-04 → 2027-12-31 | |
| N/A | Active | Al-Azhar University | 36 | 2025-12-01 → 2027-07-01 | |
| N/A | By Invitation | University of Zagreb | 86 | 2026-06-01 → 2026-12-31 | |
| N/A | By Invitation | Menoufia University | 88 | 2026-01-31 → 2026-10-30 | |
| Phase 2/3 | Not Yet Recruiting | Misr International University | 90 | 2027-12 → 2028-12 | |
| N/A | Not Yet Recruiting | Ain Shams University | 42 | 2026-07 → 2026-08 | |
| N/A | Not Yet Recruiting | University Hospital Ulm | 60 | 2026-06-20 → 2027-05-01 | |
| Phase 4 | Not Yet Recruiting | Colgate Palmolive | 60 | 2026-10-08 → 2026-12-23 |
Source: ClinicalTrials.gov. Trials matched by ingredient name.
9 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
| Date | Submission | Document |
|---|---|---|
| May 15, 2018 | SUPPL -8 | View Letter (PDF) |
| Jan 10, 2013 | SUPPL -7 | View Letter (PDF) |
| Jan 9, 2003 | SUPPL -6 | View Letter (PDF) |
Source: Drugs@FDA application documents.
No patent or exclusivity listings for this strength.